Vebrekotuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vebrekotuzumab, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC [Phase 2]